货号:A308538
同义名:
1,9-trans-9,5-cis-Sweroside
Sweroside是一种从Swertia bimaculata草本植物中分离纯化的天然产物,具有强肝脏保护、抗骨质疏松、类胰岛素和创伤愈合作用。它能在300 μM时无细胞毒性地抑制Melan-a细胞中的黑色素生成,并且降低酪氨酸酶、酪氨酸酶相关蛋白1(TRP-1)和TRP-2蛋白的生成。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | diphenolase ↓ ↑ | monophenolase ↓ ↑ | tyrosinase ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hexylresorcinol |
+++
diphenolase, IC50: 0.85 μM |
++
monophenolase, IC50: 1.24 μM |
+++
monophenolase, IC50: 0.85 μM diphenolase, IC50: 0.85 μM |
99%+ | |||||||||||||||
| Aloin | ✔ | 98% (mixture of A&B) | |||||||||||||||||
| Arbutin |
+
tyrosinase, IC50: 1.09 mM |
98% | |||||||||||||||||
| Monobenzone | ✔ | 98% | |||||||||||||||||
| Deoxyarbutin |
++++
tyrosinase, IC50: 50 nM |
98% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 描述 | Sweroside, a natural product isolated and purified from the herbs of Swertia bimaculata with strong hepatoprotective, anti-osteoporotic, insulin-mimicking, and wound-healing effects, can inhibit potent melanogenesis in melan-a cells at 300uM without cytotoxicity, also decreases tyrosinase, tyrosinase-related protein-1 (TRP-1) and TRP-2 protein production in melan a cells. |
| Concentration | Treated Time | Description | References | |
| SH-SY5Y cells | 302.0 ng/mL | 24 h | To evaluate the effect of Sweroside on the expression of CREB and GAP-43. The results showed that Sweroside significantly increased the expression of CREB and GAP-43 (P<0.01). | Drug Des Devel Ther. 2019 Jul 16;13:2357-2370. |
| Bone marrow-derived macrophages (BMDMs) | 100 µM | 1 h | Inhibited NLRP3 inflammasome activation, reduced IL-1β secretion and caspase-1 (p20) production | Int J Mol Sci. 2020 Apr 17;21(8):2790. |
| H9c2 cardiomyoblast cells | 2-20 μM | 24 h | To evaluate the protective effects of Sweroside on aconitine-induced toxicity in H9c2 cells. Results showed that Sweroside significantly increased cell viability, reduced LDH leakage, and inhibited aconitine-induced oxidative stress and intracellular ROS production. | Front Pharmacol. 2018 Oct 25;9:1138. |
| RAW264.7 cells | 20, 40, 80 μM | 7 days | To investigate the anti-inflammatory effect of sweroside in LPS-induced RAW264.7 cells. Results showed that sweroside significantly inhibited cell proliferation, reduced the production of NO, PGE2, and ROS, and alleviated inflammation by activating SIRT1 to suppress NF-κB and promote FOXO1 signaling pathways. | Molecules. 2019 Mar 1;24(5):872. |
| Administration | Dosage | Frequency | Description | References | ||
| C57BL/6 N mice | TAC-induced heart failure model | Intraperitoneal injection | 15, 30, 60 mg/kg | Once daily for 8 weeks | Sweroside significantly improved cardiac function in TAC-induced mice, increased EF and FS, and reduced myocardial fibrosis and cardiomyocyte hypertrophy. | Redox Biol. 2024 Aug;74:103223 |
| C57BL/6J mice | ANIT-induced cholestatic liver injury model | Oral | 120 mg/kg | Once daily for 5 consecutive days | To evaluate the protective effect of Sweroside on ANIT-induced cholestatic liver injury, results showed that Sweroside attenuated liver injury by restoring bile acid synthesis and transport to normal levels and suppressing pro-inflammatory responses. | Acta Pharmacol Sin. 2016 Sep;37(9):1218-28 |
| Zebrafish (Danio rerio) | Scopolamine-induced memory deficits model | Immersion | 2.79, 8.35, and 13.95 nM | Once daily for 8 days | Sweroside significantly improved the Sco-induced decrease of the cholinergic system activity and brain oxidative stress. These results suggest that sweroside exerts a significant effect on anxiety and cognitive impairment, driven in part by the modulation of the cholinergic system activity and brain antioxidant action. | Molecules. 2022 Sep 11;27(18):5901 |
| C57BL/6 mice | Methionine-choline-deficient (MCD) diet-induced NASH model | Intraperitoneal injection | 5 and 30 mg/kg | Once daily for two weeks | Alleviated hepatic inflammation, fat accumulation, and fibrosis, suppressed hepatic NLRP3 inflammasome activation, and reduced IL-1β and caspase-1 production | Int J Mol Sci. 2020 Apr 17;21(8):2790. |
| Sprague-Dawley rats | Aconitine-induced arrhythmia model | Intraperitoneal injection | 50 mg/kg | Once daily for 5 days | To evaluate the protective effects of Sweroside on aconitine-induced arrhythmias. Results showed that Sweroside significantly reduced the incidence of arrhythmias and lowered the risk of ventricular fibrillation and sudden death. | Front Pharmacol. 2018 Oct 25;9:1138. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.79mL 0.56mL 0.28mL |
13.95mL 2.79mL 1.40mL |
27.91mL 5.58mL 2.79mL |
|
| CAS号 | 14215-86-2 |
| 分子式 | C16H22O9 |
| 分子量 | 358.34 |
| SMILES Code | O=C1C2=CO[C@@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)[C@H](C=C)[C@]2([H])CCO1 |
| MDL No. | MFCD09954487 |
| 别名 | 1,9-trans-9,5-cis-Sweroside |
| 运输 | 蓝冰 |
| InChI Key | VSJGJMKGNMDJCI-ZASXJUAOSA-N |
| Pubchem ID | 161036 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, inert atmosphere, store in freezer, under -20°C |
| 溶解方案 |
DMSO: 105 mg/mL(293.02 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 50 mg/mL(139.53 mM),配合低频超声助溶 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1